Category: Immunogenicity Testing

Navigating the Immunogenicity Lifecycle: Strategies for ADA, nAb & Cytokine Profiling

Posted by adminacc in Immunogenicity Testing
No Comments
Share
Like
Like

For developers of biologics, cell therapies, and vaccines, “How immunogenic is my drug?” is one of the most critical questions in the development pipeline. An unwanted immune response can compromise safety, alter pharmacokinetics, and neutralize therapeutic efficacy. Answering this question requires more than a single assay. It demands a comprehensive lifecycle approach that looks beyond […]

21 Oct

A Scientist’s Guide to Immunogenicity Testing in Biologics

Posted by adminacc in Immunogenicity Testing
No Comments
Share
Like
Like

In the development of biologic drugs—from monoclonal antibodies to gene therapies—few challenges are as critical and complex as understanding immunogenicity. The potential for a therapeutic to elicit an unwanted immune response in patients can profoundly impact its safety and efficacy. For drug developers, a robust immunogenicity testing strategy is not just a regulatory requirement; it’s […]